Lonza Group

Lonza Group

World Rank (Aug-2026)
496
Market Cap (Aug-2026)
51.870 Billion USD
World Rank (Jan-05-2024)
598
Market Cap (Jan-05-2024)
30.535 Billion USD
World Rank (Jul-30-2023)
414
Market Cap (Jul-30-2023)
44.006 Billion USD
World Rank (Jan-07-2022)
316
Market Cap (Jan-07-2022)
57.618 Billion USD
World Rank (Jan-01-2021)
345
Market Cap (Jan-01-2021)
47.276 Billion USD
Headquarters Country
Switzerland
Top Healthcare Companies in Europe
Top Technology Companies in Europe
Top Pharmaceutical Companies in Europe
CEO
Pierre-Alain Ruffieux
Chairman
Albert M. Baehny
Employee Count
17,500
Employee Count as of Date
As on 2023
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
8,282 Million USD
Annual Operating Income in USD
1,722 Million USD
Annual Net Income in USD
-349 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
22,708 Million USD
Total Liabilities in USD
12,606 Million USD
Total Equity in USD
10,102 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
Biopharmaceutical
Chemicals
Biotechnology
Company Website
LONZA GROUP AG
Wikipedia
Wikipedia
Yahoo
Yahoo @ Switzerland
Facebook
Facebook
Company Profile

Pharmaceutical, Bio Technology and Chemical Company with headquarters is in Basel, Switzerland.

Annual Results Summary

LONZA GROUP - Annual Results - Revenue and Net Income - in Million CHF:

Year - EndingRevenueNet Income
Dec-20226,2231,215
Dec-20215,4092,944
Dec-20204,508869
Dec-20195,920645
Dec-20185,542559
Balance Sheet Summary

Total Assets as on Dec-2022 was 17,356 Million CHF.

Total Liabilities as on Dec-2022 was 6,691 Million CHF.

Total Equity as on Dec-2022 was 10,665 Million CHF.

Founded Year
1897
Stock Category
S&P EUROPE 350
Stock Exchange
Switzerland

Share